OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development. OWKIN's proprietary platform, OWKIN Socrates uses machine learning-based modeling to analyze molecular, imaging libraries and patient datasets to uncover complex biomarker patterns that cause disease. OWKIN partners with leading pharmaceutical companies including Amgen and Actelion and the Company has programs in development with Institut Curie, Centre Leon Berard and Saint Louis Hospital.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/16/18 | $11,000,000 | Series A |
Cathay Innovation NJF Capital Otium Venture  Plug & Play Ventures | undisclosed |
| 05/23/18 | undisclosed | Series A Extension |
